Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.

Saved in:
Bibliographic Details
Title: Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
Authors: Sheik Ali S; King's College London School of Medicine, London, England., Goddard AL; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Luke JJ; Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Donahue H; Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Todd DJ; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Werchniak A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Vleugels RA; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Source: JAMA dermatology [JAMA Dermatol] 2015 Feb; Vol. 151 (2), pp. 195-9.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25321335
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sheik+Ali+S%22">Sheik Ali S</searchLink>; King's College London School of Medicine, London, England.<br /><searchLink fieldCode="AU" term="%22Goddard+AL%22">Goddard AL</searchLink>; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Luke+JJ%22">Luke JJ</searchLink>; Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Donahue+H%22">Donahue H</searchLink>; Melanoma Disease Center, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Todd+DJ%22">Todd DJ</searchLink>; Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Werchniak+A%22">Werchniak A</searchLink>; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Center for Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Vleugels+RA%22">Vleugels RA</searchLink>; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589530%22">JAMA dermatology</searchLink> [JAMA Dermatol] 2015 Feb; Vol. 151 (2), pp. 195-9.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589530 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686068%22">21686068 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25321335
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamadermatol.2014.2233
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 195
    Titles:
      – TitleFull: Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sheik Ali S
      – PersonEntity:
          Name:
            NameFull: Goddard AL
      – PersonEntity:
          Name:
            NameFull: Luke JJ
      – PersonEntity:
          Name:
            NameFull: Donahue H
      – PersonEntity:
          Name:
            NameFull: Todd DJ
      – PersonEntity:
          Name:
            NameFull: Werchniak A
      – PersonEntity:
          Name:
            NameFull: Vleugels RA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2015 Feb
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6084
          Numbering:
            – Type: volume
              Value: 151
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: JAMA dermatology
              Type: main
ResultId 1